---
title: "Jianfeng Weixian-U · Weixianyou OTC E-commerce Case — Nine Health"
url: https://www.nine-health.cn/en/cases/weixianyou/
lang: en-US
publisher: "和众利健科技（深圳）有限公司"
contact: "18126259547"
updated: 2026-09-09
---

# Jianfeng Weixian-U · Weixianyou OTC E-commerce Case — Nine Health

Building self-operated, tier-2 distribution and instant-retail channels around differentiated product perception, driving the brand from zero in the mainland market through compliant content and hero-SKU operations.

## In One Sentence
Building self-operated, tier-2 distribution and instant-retail channels around differentiated product perception, driving the brand from zero in the mainland market through compliant content and hero-SKU operations.

## Project Background
Weixianyou (formerly Weixian-U) compound vitamin U tablets are an OTC product of Jianfeng Weixian-U Co., Ltd. After re-entering the mainland market, the project had to rebuild brand awareness under strong competition, complete multi-channel compliant listing, and maintain a stable terminal price order.

## Engagement Overview
- Period: Jan 2022 — Dec 2026
- Core product: Compound Vitamin U tablets, 30-tablet pack
- Channels: Alibaba/JD self-operated, tier-2 e-commerce distribution, instant retail
- Scope: E-commerce operations, content marketing, compliance review, channel expansion

## Operations Strategy
- **Multi-channel Compliant Listing**: Advanced the qualification, product and fulfillment chains for Alibaba Health, JD Pharmacy, tier-2 distribution and instant retail, first building a sustainable operating base.
- **Focused Hero-SKU Operations**: Anchored on the 30-tablet hero SKU, using single-bottle and multi-bottle bundles to meet different purchase needs and avoid scattered resources.
- **Tiered Content & Search Layout**: Organized compliant content around brand, product process, usage scenarios and consumer education, and laid out both brand-term and category search terms.
- **Unified Price Control & Distribution**: Balanced self-operated scale and distribution coverage through price-limit agreements, unified materials, promotion approval and daily inspection.

## Phased Operating Results
- **Store GMV**: 15k → 600k (40×)
- **Search & brand-term index**: 2,000 → 20,000 (10×)
- **Conversion rate**: 6% → 18% (+12 pts)
- **Avg. order value**: 71 RMB → 95 RMB (+33.8%)
- **ROAS**: 4 → 8.5 (+112.5%)
- **Repurchase rate**: 5% → 20% (4×)

## Provider
Nine Health Technology (Shenzhen) Co., Ltd. — 20+ years in pharmaceutical marketing. Phone: +86-18126259547. More cases at /en/cases/.

---

Source: [Nine Health](https://www.nine-health.cn/en/cases/weixianyou/) · Publisher: 和众利健科技（深圳）有限公司 · Phone: +86-18126259547